Winfried Häuser

Q: What Schools Are Affiliated With Winfried Häuser

Winfried Häuser is affiliated with the following schools: University of Cologne, Technical University of Munich, University of Bonn

Winfried Häuser's AcademicInfluence.com Rankings

Winfried Häuser

Computer Science

#4840

World Rank

#5110

Historical Rank

Computational Linguistics

#552

World Rank

#560

Historical Rank

Machine Learning

#1082

World Rank

#1098

Historical Rank

Artificial Intelligence

#1309

World Rank

#1333

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Winfried Häuser Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Winfried Häuser's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia (2011) (1180)
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. (2016) (849)
EULAR revised recommendations for the management of fibromyalgia (2016) (716)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. (2013) (477)
Fibromyalgia Prevalence, Somatic Symptom Reporting, and the Dimensionality of Polysymptomatic Distress: Results From a Survey of the General Population (2013) (385)
Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials (2010) (371)
Cannabis-based medicines for chronic neuropathic pain in adults. (2018) (357)
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. (2009) (338)
Guidelines on the management of fibromyalgia syndrome – A systematic review (2010) (329)
Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. (2009) (328)
[The German Version of the Childhood Trauma Questionnaire (CTQ): psychometric characteristics in a representative sample of the general population]. (2012) (259)
Efficacy of Cognitive-Behavioral Therapies in Fibromyalgia Syndrome — A Systematic Review and Metaanalysis of Randomized Controlled Trials (2010) (254)
Cognitive behavioural therapies for fibromyalgia. (2013) (224)
Maltreatment in childhood and adolescence: results from a survey of a representative sample of the German population. (2011) (222)
Treatment of fibromyalgia syndrome with gabapentin and pregabalin – A meta-analysis of randomized controlled trials (2009) (221)
Nocebo phenomena in medicine: their relevance in everyday clinical practice. (2012) (214)
Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis (2012) (209)
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome (2011) (207)
Emotional, physical, and sexual abuse in fibromyalgia syndrome: A systematic review with meta‐analysis (2011) (200)
Nociplastic pain: towards an understanding of prevalent pain conditions (2021) (200)
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. (2010) (176)
The Role of Antidepressants in the Management of Fibromyalgia Syndrome (2012) (156)
Treatment of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines with Special Emphasis on Complementary and Alternative Therapies (2013) (150)
Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population (2011) (144)
Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias (2018) (143)
The development of fibromyalgia – I: Examination of rates and predictors in patients with rheumatoid arthritis (RA) (2011) (142)
Non-specific, functional, and somatoform bodily complaints. (2012) (141)
Review of pharmacological therapies in fibromyalgia syndrome (2014) (133)
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. (2008) (132)
Fibromyalgia diagnosis and diagnostic criteria (2011) (132)
European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management (2018) (128)
Efficacy of acupuncture in fibromyalgia syndrome--a systematic review with a meta-analysis of controlled clinical trials. (2010) (127)
The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents (2017) (125)
Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014 (2014) (125)
Efficacy, tolerability and safety of cannabis‐based medicines for chronic pain management – An overview of systematic reviews (2018) (124)
Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials (2012) (124)
Posttraumatic stress disorder in fibromyalgia syndrome: Prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome (2013) (124)
Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – A systematic review and meta‐analysis of randomized controlled trials (2018) (124)
Determinants of health-related quality of life in patients with chronic liver diseases. (2004) (121)
Efficacy of hydrotherapy in fibromyalgia syndrome--a meta-analysis of randomized controlled clinical trials. (2009) (117)
Considering the potential for an increase in chronic pain after the COVID-19 pandemic (2020) (115)
Predictors of reduced health‐related quality of life in adults with coeliac disease (2006) (112)
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. (2011) (112)
Validation of the Fibromyalgia Survey Questionnaire within a Cross-Sectional Survey (2012) (110)
Cannabinoids for fibromyalgia. (2016) (110)
Health-related quality of life in adult coeliac disease in Germany: results of a national survey (2006) (109)
Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy—magnitude and patient-related predictors (2011) (109)
[Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014]. (2014) (106)
Fibromyalgia syndrome: classification, diagnosis, and treatment. (2009) (100)
Facts and myths pertaining to fibromyalgia (2018) (100)
[What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]. (2008) (99)
S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn” (2008) (96)
Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus (1997) (94)
Anxiety and depression in adult patients with celiac disease on a gluten-free diet. (2010) (94)
Long-term opioid use in non-cancer pain. (2014) (92)
Biopsychosocial Predictors of Health-Related Quality of Life in Patients With Chronic Hepatitis C (2004) (91)
Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population - a cross-sectional survey (2014) (91)
Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis) (2016) (90)
Diagnostik und Therapie des Morbus Crohn: Ergebnisse einer Evidenz-basierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zusammen mit dem Kompetenznetz Chronisch entzündliche Darmerkrankungen (2008) (90)
Systematic review and meta‐analysis of cannabinoids in palliative medicine (2018) (90)
Was sind die Kernsymptome des Fibromyalgiesyndroms? (2007) (90)
Adverse Events Attributable to Nocebo in Randomized Controlled Drug Trials in Fibromyalgia Syndrome and Painful Diabetic Peripheral Neuropathy: Systematic Review (2012) (88)
The Longitudinal Outcome of Fibromyalgia: A Study of 1555 Patients (2011) (87)
Considering the potential for an increase in chronic pain following the COVID-19 pandemic. (2020) (86)
Frequency of child maltreatment in a representative sample of the German population (2013) (86)
Anticonvulsants for fibromyalgia. (2013) (85)
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia (2018) (84)
Development and Validation of the Celiac Disease Questionnaire (CDQ), a Disease-specific Health-related Quality of Life Measure for Adult Patients With Celiac Disease (2007) (83)
A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome (2015) (80)
Efficacy, acceptability and safety of guided imagery/hypnosis in fibromyalgia – A systematic review and meta‐analysis of randomized controlled trials (2017) (80)
Characterization and distribution of angiotensin II receptor subtypes in the mouse brain. (1998) (79)
Efficacy of hypnosis/guided imagery in fibromyalgia syndrome - a systematic review and meta-analysis of controlled trials (2011) (79)
Management of fibromyalgia syndrome – an interdisciplinary evidence-based guideline (2008) (76)
Efficacy of EMG- and EEG-Biofeedback in Fibromyalgia Syndrome: A Meta-Analysis and a Systematic Review of Randomized Controlled Trials (2013) (75)
Long‐term opioid therapy for chronic non‐cancer pain in Germany (2016) (74)
Management of fibromyalgia: practical guides from recent evidence-based guidelines. (2017) (72)
Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation (2018) (71)
Questions on life satisfaction (FLZM) in inflammatory bowel disease (2004) (71)
Fibromyalgia syndrome: under-, over- and misdiagnosis. (2019) (71)
Short-Term Stress, but Not Mucosal Healing Nor Depression Was Predictive for the Risk of Relapse in Patients with Ulcerative Colitis: A Prospective 12-Month Follow-up Study (2013) (69)
Cannabinoids in Pain Management and Palliative Medicine. (2017) (69)
A Cluster Within the Continuum of Biopsychosocial Distress Can Be Labeled “Fibromyalgia Syndrome” — Evidence from a Representative German Population Survey (2009) (68)
[Clinical practice guideline on diagnosis and treatment of Crohn's disease]. (2008) (67)
Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. (2012) (67)
Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials (2016) (66)
Fibromyalgia syndrome: A somatoform disorder? (2014) (65)
Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia (2014) (65)
Validation of the German version of the Chronic Liver Disease Questionnaire (2004) (64)
Comorbid fibromyalgia: A qualitative review of prevalence and importance (2018) (63)
The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity (2015) (62)
Efficacy, Tolerability, and Safety of Hypnosis in Adult Irritable Bowel Syndrome: Systematic Review and Meta-Analysis (2014) (59)
Classification and Clinical Diagnosis of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines (2013) (59)
Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review. (2014) (58)
[S2k guidelines diverticular disease/diverticulitis]. (2014) (57)
Diagnosis of Fibromyalgia Syndrome—A Comparison of Association of the Medical Scientific Societies in Germany, Survey, and American College of Rheumatology Criteria (2010) (57)
[Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies]. (2016) (57)
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension (2003) (55)
Ätiologie und Pathophysiologie des Fibromyalgiesyndroms (2012) (55)
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. (2013) (53)
Medical Cannabis for Older Patients (2018) (53)
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain (2019) (52)
[The childhood trauma screener (CTS) - development and validation of cut-off-scores for classificatory diagnostics]. (2013) (52)
The German fibromyalgia consumer reports – a cross-sectional survey (2012) (52)
Diagnostic confounders of chronic widespread pain: not always fibromyalgia (2017) (52)
Chronische Schmerzen, Schmerzkrankheit und Zufriedenheit der Betroffenen mit der Schmerzbehandlung in Deutschland (2014) (51)
The opioid epidemic and the long-term opioid therapy for chronic noncancer pain revisited: a transatlantic perspective. (2016) (51)
Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. (2017) (51)
Unravelling Fibromyalgia-Steps Toward Individualized Management. (2017) (51)
Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews (2016) (51)
The Efficacy, Safety and Applications of Medical Hypnosis. (2016) (51)
Prävalenz und Prädiktoren von Schmerzen in mehreren Körperregionen (2009) (50)
Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary. (1997) (50)
[Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain]. (2015) (50)
Demographic and clinical features of patients with fibromyalgia syndrome of different settings: a gender comparison. (2011) (50)
[Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis]. (2012) (50)
Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. (2004) (49)
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. (2012) (49)
Impairment of health‐related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety (2008) (49)
[Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. (2012) (49)
Differential Expression of AT1 Receptors in the Pituitary and Adrenal Gland of SHR and WKY (2003) (49)
Ätiopathogenese und Pathophysiologie des Fibromyalgiesyndroms und chronischer Schmerzen in mehreren Körperregionen (2008) (49)
Definition, Klassifikation und Diagnose des Fibromyalgiesyndroms (2008) (49)
Diagnosis and diagnostic tests for fibromyalgia (syndrome). (2012) (48)
Self-Compassion as a Resource in the Self-Stigma Process of Overweight and Obese Individuals (2015) (48)
Polysymptomatic Distress in Patients With Rheumatoid Arthritis: Understanding Disproportionate Response and Its Spectrum (2014) (47)
A Systematic Review and Meta-Analysis of Qigong for the Fibromyalgia Syndrome (2013) (47)
Medikamentöse Therapie des Fibromyalgiesyndroms (2008) (47)
Efficacy and harms of long‐term opioid therapy in chronic non‐cancer pain: Systematic review and meta‐analysis of open‐label extension trials with a study duration ≥26 weeks (2019) (47)
Diagnosis of Fibromyalgia: Disagreement Between Fibromyalgia Criteria and Clinician‐Based Fibromyalgia Diagnosis in a University Clinic (2019) (46)
Empfehlungen der aktualisierten Leitlinie LONTS (2015) (45)
Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia (2013) (45)
Prevalence of Chronic Disabling Noncancer Pain and Associated Demographic and Medical Variables: A Cross-Sectional Survey in the General German Population (2015) (45)
[Prevalence and predictors of pain in several body regions. Results of a representative German population survey]. (2009) (45)
[Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. (2012) (45)
[Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. (2012) (44)
Physiotherapie und physikalische Verfahren beim Fibromyalgiesyndrom (2012) (44)
Validation of the Patient-Doctor-Relationship Questionnaire (PDRQ-9) in a Representative Cross-Sectional German Population Survey (2014) (43)
Psychotherapie bei Patienten mit Fibromyalgiesyndrom (2008) (43)
Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome. (2015) (42)
[Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. (2012) (41)
EULAR recommendations for management of fibromyalgia (2017) (41)
Revised chronic widespread pain criteria: development from and integration with fibromyalgia criteria (2019) (40)
Der Childhood Trauma Screener (CTS) – Entwicklung und Validierung von Schwellenwerten zur Klassifikation (2013) (40)
[Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain]. (2008) (39)
[Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]. (2015) (39)
Medical use of cannabis products (2016) (39)
Increased AT(1) receptor expression and mRNA in kidney glomeruli of AT(2) receptor gene-disrupted mice. (2001) (38)
Allgemeine Behandlungsgrundsätze, Versorgungskoordination und Patientenschulung beim Fibromyalgiesyndrom und chronischen Schmerzen in mehreren Körperregionen (2008) (38)
What Is Fibromyalgia, How Is It Diagnosed, and What Does It Really Mean? (2014) (38)
Multimodale Therapie des Fibromyalgiesyndroms (2008) (37)
[Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups]. (2017) (36)
The Problematic Nature of Fibromyalgia Diagnosis in the Community (2019) (36)
Opioids for chronic non‐cancer neuropathic pain. An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks duration (2019) (35)
Increased Angiotensin II AT1 Receptor Expression in Paraventricular Nucleus and Hypothalamic-Pituitary-Adrenal Axis Stimulation in AT2 Receptor Gene Disrupted Mice (2002) (35)
Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats. (1990) (34)
The Association Among Childhood Maltreatment, Somatic Symptom Intensity, Depression, and Somatoform Dissociative Symptoms in Patients with Fibromyalgia Syndrome: A Single-Center Cohort Study (2013) (34)
Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients. (2015) (33)
Patterns of Childhood Abuse and Neglect in a Representative German Population Sample (2016) (33)
Self-Reported Childhood Maltreatment and Traumatic Events among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis (2017) (33)
Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. (2020) (33)
Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia (2009) (33)
S2k-Leitlinie Divertikelkrankheit/Divertikulitis (2018) (33)
Behandlung und Krankheitskosten des Fibromyalgiesyndroms in Deutschland (2011) (33)
Predictors of Irritable Bowel-Type Symptoms and Healthcare-Seeking Behavior Among Adults With Celiac Disease (2007) (32)
[Fibromyalgia syndrome. General principles and coordination of clinical care and patient education]. (2012) (32)
Functional bowel disorders in adults. (2012) (32)
Opioide bei chronischem Arthroseschmerz (2015) (32)
Opioids for chronic low back pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks of double‐blind duration (2019) (32)
Widespread pain in older Germans is associated with posttraumatic stress disorder and lifetime employment status – Results of a cross-sectional survey with a representative population sample (2012) (32)
Erratum zu: Opioide bei chronischem Kreuzschmerz: Systematische Übersicht und Metaanalyse der Wirksamkeit, Verträglichkeit und Sicherheit in randomisierten, placebokontrollierten Studien über mindestens 4 Wochen (2015) (32)
Biopsychosocial Determinants of Health-Related Quality of Life After Ileal Pouch Anal Anastomosis for Ulcerative Colitis* (2004) (32)
Widespread Pain and Low Widespread Pain Index Scores among Fibromyalgia-positive Cases Assessed with the 2010/2011 Fibromyalgia Criteria (2016) (32)
Quality of Life of Celiac Patients in Brazil: Questionnaire Translation, Cultural Adaptation and Validation (2018) (31)
Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study. (2020) (31)
Methodische Grundlagen für die Entwicklung der Leitlinienempfehlungen (Methodenreport) (2008) (31)
Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: surveys with patients of three different settings. (2014) (31)
Is Europe also facing an opioid crisis?—A survey of European Pain Federation chapters (2021) (31)
Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen? (2015) (31)
Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS) (2019) (31)
Spa Treatment (Balneotherapy) for Fibromyalgia—A Qualitative-Narrative Review and a Historical Perspective (2013) (31)
Social Security Work Disability and Its Predictors in Patients With Fibromyalgia (2014) (31)
[Treatment of non-specific, functional and somatoform bodily complaints]. (2014) (31)
[Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety]. (2016) (31)
[Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (30)
Efficacy, acceptability and safety of Internet‐delivered psychological therapies for fibromyalgia syndrome: A systematic review and meta‐analysis of randomized controlled trials (2018) (30)
European* clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain (2021) (30)
Primary and Secondary Fibromyalgia Are The Same: The Universality of Polysymptomatic Distress (2018) (30)
Validierung der deutschen Version der regionalen Schmerzskala zur Diagnose des Fibromyalgiesyndroms (2010) (30)
The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression (1998) (30)
The impact of body weight and depression on low back pain in a representative population sample. (2014) (29)
[Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009]. (2011) (29)
Validierung der Deutschen Version (Kompetenznetz „Chronisch entzündliche Darmerkrankungen”) des Inflammatory Bowel Disease Questionnaire IBDQ-D (2006) (29)
Fibromyalgia syndrome: novel therapeutic targets. (2016) (29)
Die deutsche Version des Childhood Trauma Questionnaire (CTQ) – psychometrische Eigenschaften in einer bevölkerungsrepräsentativen Stichprobe (2011) (29)
Kinin B1 and B2 receptor mRNA expression in the hypothalamus of spontaneously hypertensive rats. (2002) (29)
[Prevalence of chronic pain in Germany. A representative survey of the general population]. (2013) (29)
Psychophysiology of visceral pain in IBS and health. (2008) (29)
Das Fibromyalgiesyndrom — eine somatoforme (Schmerz)störung? (2006) (29)
[Definition, diagnostics and therapy of chronic widespread pain and the (so-called) fibromyalgia syndrome in children and adolescents : Updated guidelines 2017]. (2017) (28)
Bradykinin increases catecholamine release via B2 receptors. (1996) (28)
Comparison of Physician‐Based and Patient‐Based Criteria for the Diagnosis of Fibromyalgia (2016) (28)
[Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline]. (2012) (28)
Systematic reviews with meta-analysis on cannabis-based medicines for chronic pain: a methodological and political minefield. (2018) (28)
[Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain]. (2020) (28)
Prävalenz chronischer Schmerzen in Deutschland (2013) (27)
[Chronic pain, pain disease, and satisfaction of patients with pain treatment in Germany. Results of a representative population survey]. (2014) (27)
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? (2002) (27)
Selective serotonin reuptake inhibitors for fibromyalgia syndrome. (2015) (27)
Guideline-recommended vs high-dose long-term opioid therapy for chronic noncancer pain is associated with better health outcomes: data from a representative sample of the German population (2018) (26)
Langzeittherapie mit Opioiden bei chronischem nicht-tumorbedingtem Schmerz (2015) (26)
[Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review]. (2016) (26)
Opioids for chronic osteoarthritis pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks double‐blind duration (2019) (26)
Modification of Noradrenaline Release in Pithed Spontaneously Hypertensive Rats by I1-Binding Sites in Addition to α2-Adrenoceptors (2003) (26)
Erratum zu: Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen? (2015) (25)
Opioide bei chronischem neuropathischem Schmerz (2014) (25)
[Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration]. (2015) (25)
Subjektive Krankheitsattributionen und Inanspruchnahme medizinischer Leistungen von Patienten mit Fibromyalgiesyndrom (2006) (24)
Cannabinoide in der palliativen Versorgung (2016) (24)
Physiotherapie, medizinische Trainingstherapie und physikalische Therapie beim Fibromyalgiesyndrom (2008) (24)
Systematic review and meta‐analysis on non‐opioid analgesics in palliative medicine (2018) (24)
The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome. (2019) (23)
Empfehlungen der zweiten Aktualisierung der Leitlinie LONTS (2020) (23)
Komplementäre und alternative Verfahren beim Fibromyalgiesyndrom (2008) (23)
[Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]. (2015) (23)
[General treatment principles, coordination of care and patient education in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (23)
Fibromyalgia and Physical Trauma: The Concepts We Invent (2014) (23)
Increased AT1 receptors in adrenal gland of AT2 receptor gene-disrupted mice (2001) (22)
Leitlinie: Definition, Pathophysiologie, Diagnostik und Therapie des Fibromyalgiesyndroms (2012) (22)
[German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies]. (2012) (22)
Effects of the AT1 Antagonist HR 720 in Comparison to Losartan on Stimulated Sympathetic Outflow, Blood Pressure, and Heart Rate in Pithed Spontaneously Hypertensive Rats (1998) (22)
The Somatic Symptom Disorder in DSM 5 risks mislabelling people with major medical diseases as mentally ill. (2013) (21)
Allgemeine Behandlungsgrundsätze, Versorgungskoordination und Patientenschulung beim Fibromyalgiesyndrom (2017) (21)
Mirtazapine for fibromyalgia in adults. (2017) (21)
Hearing loss in fibromyalgia? Somatic sensory and non-sensory symptoms in patients with fibromyalgia and other rheumatic disorders. (2012) (21)
[Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain]. (2008) (21)
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 (2021) (20)
Family physician-patient relationship and frequent attendance of primary and specialist health care: Results from a German population-based cohort study. (2016) (20)
[Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties]. (2013) (20)
Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ) (2015) (20)
Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot study. (2011) (20)
WITHDRAWN: Anticonvulsants for fibromyalgia. (2017) (19)
[Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]. (2015) (19)
[Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (19)
Erratum zu: Langzeittherapie mit Opioiden bei chronischem nicht-tumorbedingtem Schmerz (2015) (19)
Angiotensin-converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats. (2001) (19)
Cannabinoids in the treatment of rheumatic diseases: Pros and cons. (2019) (18)
Fibromyalgiesyndrom bei Kindern und Jugendlichen (2008) (18)
Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts (2007) (18)
Lebensqualität bei chronisch entzündlichen Darmerkrankungen (CED): die deutsche Version des Inflammatory Bowel Disease Questionnaire (IBDQ-D) zur krankheitsspezifischen Lebensqualitätsmessung – erste Anwendung und Vergleich mit anderen internationalen Fassungen (2005) (18)
[Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)]. (2006) (18)
Chemical lesion of the inferior olive reduces [125I]Sarcosine1–Angiotensin II binding to AT2 receptors in the cerebellar cortex of young rats (1998) (18)
Lebensqualitätsmessung in der Gastroenterologie - Konzepte, Instrumente und Probleme (2001) (18)
[Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010]. (2013) (18)
Administrative Prävalenz, Behandlung und Krankheitskosten der somatoformen Schmerzstörung (2013) (18)
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases (2016) (18)
Is the association of self-reported childhood maltreatments and adult fibromyalgia syndrome attributable to depression? A case control study. (2012) (18)
Aktualisierte S3-Leitlinie Colitis ulcerosa (2019) (18)
Opioide bei chronischen nicht-tumorbedingten Schmerzen – gibt es Unterschiede? (2014) (18)
Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren Körperregionen und des (sog.) Fibromyalgiesyndroms bei Kindern und Jugendlichen (2012) (18)
Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie (2016) (17)
Der deutsche Fibromyalgieverbraucherbericht (2012) (17)
Opioidtherapiemissbrauch bei anhaltender somatoformer Schmerzstörung (2001) (17)
Medical Cannabis Use by Rheumatology Patients Following Recreational Legalization: A Prospective Observational Study of 1000 Patients in Canada (2020) (17)
[Functional somatic pain syndromes: summary of hypotheses of their overlap and etiology]. (2004) (17)
Validierung der deutschen Version der Fatigue Impact Scale FIS-D (2003) (17)
Cannabidiol (2020) (17)
[Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain]. (2015) (17)
New treatment options for fibromyalgia: critical appraisal of duloxetine (2008) (17)
[Opioids in chronic noncancer pain-are opioids different? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week's duration]. (2015) (17)
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain (2021) (16)
Definition, Klassifikation, klinische Diagnose und Prognose des Fibromyalgiesyndroms (2017) (16)
Methodenreport zur Erstellung der Leitlinie (2012) (16)
Maltreatment in Childhood and Adolescence (2011) (16)
Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study (2005) (16)
Methodenreport der Leitlinie 2017 zum Fibromyalgiesyndrom (2017) (16)
2016 modified American College of Rheumatology fibromyalgia criteria, ACTTION-APS Pain Taxonomy criteria and the prevalence of fibromyalgia. (2020) (15)
A paradigm change to inform fibromyalgia research priorities by engaging patients and health care professionals (2017) (15)
[Fibromyalgia in the legal procedures of the german sozialgericht -- psychosocial risk factors and predictors of health care utilization]. (2005) (15)
Fibromyalgia Syndrome and Myofascial Pain Syndromes (2010) (15)
[Alternative and complementary therapies in fibromyalgia syndrome]. (2008) (15)
Das Fibromyalgiesyndrom als psychosomatische Erkrankung - Empfehlungen aktueller evidenzbasierter Leitlinien zu Diagnostik und Therapie (2013) (15)
Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2018) (14)
Medical cannabis: strengthening evidence in the face of hype and public pressure (2019) (14)
Patient-related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross-sectional survey. (2013) (14)
Treat‐to‐Target Strategy for Fibromyalgia: Opening the Dialogue (2017) (14)
[Multicomponent therapy for treatment of fibromyalgia syndrome]. (2008) (14)
Funktionelle somatische Schmerzsyndrome (2004) (14)
Antipsychotics for fibromyalgia in adults. (2016) (14)
[Fibromyalgia syndrome: guideline principle for a fiction?]. (2008) (14)
Chronische Schmerzen, Schmerzkrankheit und Zufriedenheit der Betroffenen mit der Schmerzbehandlung in Deutschland (2014) (14)
Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system. (1999) (14)
Hypnose in der Gastroenterologie (2003) (14)
Schritte zu einer symptombasierten Diagnose des Fibromyalgiesyndroms (2008) (14)
All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study (2020) (14)
Cannabinoids in Pain Management and Palliative Medicine An Overview of Systematic Reviews and Prospective Observational Studies (2017) (13)
Ätiologie und Pathophysiologie des Fibromyalgiesyndroms (2017) (13)
[Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings]. (2008) (13)
[Complementary and alternative procedures for fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (13)
A comparison of the clinical features of fibromyalgia syndrome in different settings. (2011) (13)
Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020) Diagnostik und Therapie der Endometriose. Leitlinie der DGGG, SGGG und OEGGG (S2k-Level, AWMF-Registernummer 015/045, August 2020) (2021) (13)
[Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome]. (2010) (13)
Expression of nitric oxide synthase isoforms in hypothalamo-pituitary-adrenal axis during the development of spontaneous hypertension in rats. (2005) (13)
Preliminary diagnostic criteria for fibromyalgia should be partially revised: Comment on the article by Wolfe et al (2011) (13)
[Validation of a German Version of the Fatigue Impact Scale FIS-D]. (2003) (12)
Obesity, depression and hip pain (2019) (12)
Ziele der Leitlinie zur Diagnostik und Therapie des Fibromyalgiesyndroms (2008) (12)
European clinical practice recommendations on opioids for chronic noncancer pain – Part 2: Special situations * (2021) (12)
Validation of the German version of the Bodily Distress Syndrome 25 checklist in a representative German population sample. (2020) (12)
Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress (1996) (12)
Acute hypothalamo-pituitary-adrenal axis response to LPS-induced endotoxemia: expression pattern of kinin type B1 and B2 receptors (2016) (12)
Psychische Störungen beim Fibromyalgiesyndrom (2013) (12)
[Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome]. (2008) (12)
Opioids for chronic non-cancer pain: a critical view from the other side of the pond. (2016) (12)
[Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse]. (2018) (12)
Influence of Imidazolines on Catecholamine Release in Pithed Spontaneously Hypertensive Rats (1995) (12)
[Pharmacological treatment of fibromyalgia syndrome]. (2008) (12)
[Position paper on medical cannabis and cannabis-based medicines in pain medicine]. (2019) (11)
Complementary and Alternative Medicine for the Treatment of Fibromyalgia (2014) (11)
Modified 2016 American College of Rheumatology Fibromyalgia Criteria, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society Pain Taxonomy, and the Prevalence of Fibromyalgia (2021) (11)
[Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) -- first application and comparison with international investigations]. (2005) (11)
Meta-analyses of pain studies: What we have learned. (2015) (11)
[Comorbid depression mediates the association of childhood/adolescent maltreatment and fibromyalgia syndrome. A study with patients from different clinical settings]. (2010) (11)
Validierung und erste Ergebnisse des deutschen QUOTE-IBD zur Erfassung der Behandlungsqualität aus Sicht der Patienten mit chronisch-entzündlichen Darmerkrankungen (2012) (11)
Nichtspezifische, funktionelle und somatoforme Körperbeschwerden (2014) (11)
[Fibromyalgia syndrome as a psychosomatic disorder - diagnosis and therapy according to current evidence-based guidelines]. (2013) (11)
Treatment of Fibromyalgia Syndrome With Antidepressants (2017) (11)
[Physiotherapy, occupational therapy and physical therapy in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (11)
Einfluss psychischer Komorbidität auf die stationäre Verweildauer internistischer Patienten im G-DRG-System (2006) (11)
Chronic primary pain: a pain-centered view of the world is too narrow. (2019) (11)
Opioide bei chronischem Kreuzschmerz (2014) (11)
[Placebo responders in randomized controlled drug trials of fibromyalgia syndrome : Systematic review and meta-analysis]. (2011) (10)
Cognitive behavioural therapies for fibromyalgia syndrome (2012) (10)
[Methodological fundamentals of the development of the guideline]. (2012) (10)
Erratum zu: Verträglichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen. Eine systematische Übersichtsarbeit von randomisierten, kontrollierten Studien (2016) (10)
Medikamentöse Therapie des Fibromyalgiesyndroms (2017) (10)
Chronische Schmerzstörung mit somatischen und psychischen Faktoren (2018) (10)
Definition, Klassifikation und Diagnose des Fibromyalgiesyndroms (2008) (10)
Prevalence of self-reported jaw pain in Germany: two cross-sectional surveys of the general German population (2016) (10)
[Multimodal therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (10)
[Psychotherapy and psychological procedures for fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (10)
Psychological therapies for chronic widespread pain and fibromyalgia syndrome. (2019) (10)
The relationship between perceived own health state and health assessments of anchoring vignettes (2016) (10)
Multimodale Therapie des Fibromyalgiesyndroms (2017) (10)
Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen (2015) (10)
Rentenbegehren, selbst eingeschätzte Schmerzintensität und Behinderung von Probanden mit Fibromyalgiesyndrom (2007) (10)
[Validation and first results of the German QUOTE-IBD to measure quality of care from the perspective of patients with inflammatory bowel disease]. (2012) (9)
Funktionelle somatische Schmerzsyndrome (2003) (9)
[Diagnosis and therapy of fibromyalgia syndrome]. (2009) (9)
Komplementäre und alternative Verfahren beim Fibromyalgiesyndrom (2013) (9)
[Abuse of opioid therapy in somatoform pain disorder. A contribution from a psychosomatic/pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases]. (2001) (9)
Kinin B 1 and B 2 receptor mRNA expression in the hypothalamus of spontaneously hypertensive rats 1 (2002) (9)
Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain (2021) (9)
Komplementäre und alternative Verfahren beim Fibromyalgiesyndrom (2008) (9)
Fibromyalgia as a chronic primary pain syndrome: issues to discuss. (2019) (9)
Ein Positionspapier zu medizinischem Cannabis und cannabisbasierten Medikamenten in der Schmerzmedizin (2019) (9)
Long-term opioid therapy for chronic noncancer pain: second update of the German guidelines (2020) (9)
Mental Disorder and Psychologic Distress in Patients With Ulcerative Colitis After Ileal Pouch-Anal Anastomosis (2005) (9)
Vermehrte Inanspruchnahme psychosomatischer Konsiliarleistungen einer kardiologisch/pulmologischen Klinik durch psychometrisches Screening (2001) (9)
[Intensity of limb pain and fatigue in fibromyalgia syndrome, depressive disorders and chronic back pain. A criterion for differentiation]. (2009) (9)
Psychosomatik viszeraler Schmerzsyndrome (2002) (9)
Physiotherapie, Ergotherapie und physikalische Verfahren beim Fibromyalgiesyndrom (2017) (9)
[Fibromyalgia -- a somatoform (pain) disorder?]. (2006) (8)
[Cannabis-based drugs : Don't pit clinical experience and systematic reviews against each other]. (2019) (8)
Leitlinienreport der zweiten Aktualisierung der S3-Leitlinie „Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen – LONTS“ (2020) (8)
[Medical expertise of chronic pain syndromes by psychotherapists]. (2002) (8)
[Measuring quality of life in gastroenterology--concepts, instruments and problems]. (2001) (8)
Komorbide depressive Störungen als Mediator der Assoziation von Misshandlungen in Kindheit/Jugend und Fibromyalgiesyndrom (2010) (8)
Norepinephrine Release Is Reduced by I1‐Receptors in Addition to a2‐Adrenoceptors (2003) (8)
[Diagnosis and therapy of fibromyalgia syndrome]. (2011) (8)
Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study. (2021) (8)
All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and clinical fibromyalgia. (2020) (8)
Chronic primary musculoskeletal pain: a new concept of nonstructural regional pain (2022) (7)
[Functional somatic pain syndromes-nomenclature]. (2004) (7)
Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors. (2003) (7)
Häufigkeit, Relevanz, Ursachen und Strategien zur Vermeidung von Medikationsfehlern (2005) (7)
The first Israeli fibromyalgia congress, February 2013. (2013) (7)
Is opioid therapy for chronic non‐cancer pain associated with a greater risk of all‐cause mortality compared to non‐opioid analgesics? A systematic review of propensity score matched observational studies (2021) (7)
Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren Körperregionen und des sogenannten Fibromyalgiesyndroms bei Kindern und Jugendlichen (2012) (7)
[Methodology report of the 2017 guidelines on fibromyalgia syndrome]. (2017) (7)
Langzeitopioidtherapie von nichttumorbedingten Schmerzen (2018) (7)
Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats. (2004) (7)
[New guidelines on functional and somatoform disorders]. (2013) (7)
[Prevalence and predictors of urogenital pain in men. Results from a survey of a representative German population sample]. (2012) (6)
[Psychophysiology of visceral pain syndromes]. (2002) (6)
Prävalenz und Prädiktoren urogenitaler Schmerzen des Manns (2012) (6)
S2k-Leitlinie Divertikelkrankheit/Divertikulitis (2014) (6)
[Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland]. (2019) (6)
Pharmacological therapies for fibromyalgia in adults - an overview of Cochrane Reviews (2018) (6)
Medicinal cannabis for chronic pain: The bermuda triangle of low‐quality studies, countless meta‐analyses and conflicting recommendations (2022) (6)
Die Qualität der Hausarzt-Patient-Beziehung. Patientenbezogene Prädiktoren in einer repräsentativen deutschen Bevölkerungsstichprobe (2016) (6)
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]. (2015) (6)
Long‐term observational studies with cannabis‐based medicines for chronic non‐cancer pain: A systematic review and meta‐analysis of effectiveness and safety (2022) (6)
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]. (2015) (6)
Evaluation of Quality of Life of Adult Patients with Celiac Disease in Argentina: From Questionnaire Validation to Assessment (2020) (6)
Long‐term outcomes of children with severe chronic pain: Comparison of former patients with a community sample (2021) (6)
[The Quality of the Family Physician-Patient Relationship. Patient-Related Predictors in a Sample Representative for the German Population]. (2016) (5)
The association of adverse childhood experiences and of resilience with chronic noncancer pain in the German adult population – A cross‐sectional survey (2018) (5)
Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten (2020) (5)
Spontaneously reported persistent symptoms related to coronavirus disease 2019 one year after hospital discharge (2022) (5)
Taxonomies for chronic visceral pain. (2020) (5)
[Psychotherapeutic procedures for fibromyalgia syndrome]. (2015) (5)
Placeboresponder in randomisierten, kontrollierten Medikamentenstudien des Fibromyalgiesyndroms (2011) (5)
Fibromyalgia syndrome: Basic knowledge, diagnosis and treatment. (2016) (5)
Psychotherapie und psychologische Verfahren beim Fibromyalgiesyndrom (2017) (5)
Abbildung komorbider psychischer Störungen bei internistischen Patienten im G-DRG-System (2005) (5)
[Self-assessed pain intensity and disability in subjects diagnosed with fibromyalgia claiming retirement pension]. (2007) (5)
[Irritable bowel syndrome]. (2004) (5)
Funktionelle somatische Schmerzsyndrome—Nomenklatur (2003) (5)
[Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield]. (2019) (5)
[Dysfunctional syndromes: their diagnostics and treatment]. (2004) (5)
Die US-amerikanische Opioidepidemie bedroht Deutschland (2020) (5)
The Polysymptomatic Distress Scale Is Simple, Useful, and Effective in Clinical Care and Clinical and Epidemiology Studies (2016) (5)
Kinin B2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats. (2003) (5)
Comment on: Efficacy of acupuncture in fibromyalgia syndrome—a systematic review with a meta-analysis of controlled clinical trials: reply (2010) (5)
Sichtbarmachung einer Fiktion – die neue S3-Leitlinie Fibromyalgiesyndrom (2009) (5)
Diagnostik und Therapie funktioneller Schmerzsyndrome (2004) (5)
Medizinalcannabis und cannabisbasierte Arzneimittel: ein Appell an Ärzte, Journalisten, Krankenkassen und Politiker für einen verantwortungsvollen Umgang (2019) (5)
Bauchschmerzen – ein Stiefkind der Schmerztherapie und Forschung? (2002) (4)
[S3 guidelines on long-term opioid treatment in non-cancer pain. Recommendations for opioid use in clinical rheumatology]. (2016) (4)
Methodenreport der aktualisierten Leitlinie „Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen – LONTS“ (2014) (4)
Äquivalenzdosen der in Deutschland verfügbaren AT1-Rezeptor-Antagonisten (2003) (4)
Endometriose und chronische überlappende Schmerzsyndrome (2021) (4)
Postoperative Pain Management in Vitreoretinal Surgery for Retinal Detachment: A Systematic Review of Randomized Controlled Trials (2018) (4)
Funktionelle somatische Schmerzsyndrome—Nomenklatur (2004) (4)
Cannabinoids for chronic neuropathic pain (2016) (4)
Prävalenz beeinträchtigender Bauchschmerzen und Menstruationsbeschwerden (2014) (4)
Long-term opioid therapy of non-cancer pain (2018) (4)
Intensität von Gliederschmerzen und Erschöpfung bei Fibromyalgiesyndrom, depressiven Störungen und chronischen Rückenschmerzen (2009) (4)
[Diagnostic criteria and therapeutic strategies of abdominal pain syndromes]. (2002) (4)
[Tobacco associated gastrointestinal disorders: smoking cessation therapy - a task for gastroenterologists]. (2002) (4)
[Visceral pain]. (2015) (4)
Chronische Schmerzen – Organisatorische Aspekte bei der Behandlung (2000) (4)
Ischemia-induced neuronal cell loss is associated with loss of atypical angiotensin type-1 receptor expression in the gerbil hippocampal formation (1999) (4)
Eine schwach negative Empfehlung ist kein kategorisches Nein (2018) (4)
Validation of the “German Inflammatory Bowel Disease Activity Index (GIBDI)”: An Instrument for Patient-Based Disease Activity Assessment in Crohn’s Disease and Ulcerative Colitis (2018) (4)
Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia (2022) (4)
[Smoking cessation. A physician's responsibility]. (2002) (4)
Gerbil Angiotensin II AT1 receptors are highly expressed in the hippocampus and cerebral cortex during postnatal development (1999) (3)
[Nicotine dependence and motivation for smoking cessation in patients of a cardiologic-pneumologic department]. (2002) (3)
[Causal illness attributions and healthcare utilization in fibromyalgia syndrome]. (2006) (3)
Das Fibromyalgiesyndrom (2020) (3)
[Endometriosis and chronic overlapping pain conditions]. (2021) (3)
Problematic use of prescribed opioids for chronic noncancer pain-no scarcity of data outside the United States. (2017) (3)
A Paradigm Change for Treatment Strategies for Fibromyalgia Syndrome Reflected by Recommendations of Recent Evidence-Based Interdisciplinary Guidelines Developed Independently in Three Countries (2014) (3)
Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey (2021) (3)
Cannabisbasierte Arzneimittel (2019) (3)
Fibromyalgiesyndrom (2008) (3)
[Methodological fundamentals for the development of the guideline]. (2008) (3)
[Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups]. (2013) (3)
Reply (2010) (3)
[Cost effectiveness of integrated internal medicine]. (2004) (3)
[Never say: "it's nothing. Improving care for patients with non-specific, functional and somatoform bodily complaints]. (2012) (3)
Cannabis use disorder in chronic pain patients: over- and underestimation in a cross-sectional observational study in three German pain management centres. (2022) (3)
Fachpsychotherapeutische Begutachtung von Schmerzkrankheiten (2002) (3)
Versorgungsforschung zu Schmerz in Deutschland (2015) (3)
Der Arztbrief (2001) (3)
Register‐based studies on cannabis‐based medicines and medical cannabis need reliable diagnoses and cannabis treatment details (2021) (3)
Der Einfluss von Interessenkonflikten auf Leitlinienempfehlungen (2017) (3)
[Frequency, relevance, causes of and strategies for prevention of medication errors]. (2005) (3)
Psychotherapie von Patienten mit Fibromyalgiesyndrom (2012) (3)
[The US opioid epidemic is threatening Germany]. (2020) (3)
Erratum zu den Artikeln https://doi.org/10.1007/s00482-020-00472-y, https://doi.org/10.1007/s00482-018-0324-4, https://doi.org/10.1007/s00482-018-0331-5 (2021) (3)
[The influence of psychiatric comorbidity on the length of hospital stay of medical inpatients within the German Diagnosis Related Groups System]. (2006) (3)
[Pain and consciousness. Articles from the summer workshop held by the German Interdisciplinary Collaboration for Pain Therapy (DIVS) in 2005]. (2007) (2)
[Prevalence of disabling abdominal pain and menstrual cramp. Results from a representative survey of the general German population]. (2014) (2)
[Efficacy of hypnosis in treatment of pain. A meta-analysis of hypnosis-induced analgesia: how effective is hypnosis?]. (2002) (2)
[Juvenile fibromyalgia syndrome]. (2008) (2)
PTSD and Fibromyalgia Syndrome: Focus on Prevalence, Mechanisms, and Impact (2015) (2)
Das Fibromyalgiesyndrom (2020) (2)
Cannabispräparate bei chronischen Schmerzen: Indikationen, Präparateauswahl, Wirksamkeit und Sicherheit (2019) (2)
[Impact of conflicts of interest on guideline recommendations : Empirical study within the second update of the German interdisciplinary S3 guidelines on fibromyalgia syndrome]. (2017) (2)
[Is an evidence-based therapy of inpatients with type 2 diabetes possible from studies used for formulating therapy guidelines?]. (2005) (2)
[A weakly negative recommendation is not an absolute "no" : Comment on AWMF guideline recommendations for cannabis-based medicines in fibromyalgia syndrome]. (2018) (2)
[Aims of the guidelines for diagnostic and treatment of fibromyalgia syndrome]. (2008) (2)
Meta-analysis of Opioids for Chronic Pain. (2019) (2)
Sagen Sie nie: „Sie haben nichts“! (2012) (2)
Subjective Cognitive Dysfunction in Patients With and Without Fibromyalgia: Prevalence, Predictors, Correlates, and Consequences (2021) (2)
Internal psychosomatic medicine within the German Diagnosis Related Groups System (2004) (2)
Fibromyalgia Syndrome—Classification, Diagnosis, and Treatment: In reply (2009) (2)
[Dosage equivalents of AT1-receptor antagonists available in Germany]. (2003) (2)
OP0070 Update of the german evidence-based guideline on the management of fibromyalgia syndrome (2013) (2)
Erratum zu: Methodenreport der aktualisierten Leitlinie „Langzeitanwendung von Opioiden bei nicht-tumorbedingten Schmerzen – LONTS“ (2015) (2)
Effektivität hypnotischer Schmerzbehandlung (2002) (2)
Pharmacological therapies for fibromyalgia (fibromyalgia syndrome) in adults - an overview of Cochrane Reviews (2021) (2)
Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis (2019) (2)
Sind Mitglieder von Fibromyalgiesyndrom-Selbsthilfegruppen „anders“? (2013) (2)
Pain management: Opioids for RA: a clinical dilemma (2017) (2)
12 Jahre S3-Leitlinie Fibromyalgiesyndrom – ein nie endender Krieg? (2017) (2)
Psychiatrische und psychosomatische Konsiliar- und Liaisonleistungen im deutschen Fallpauschalensystem (2006) (2)
[Long-term Application of Opioids for Non-Tumor Associated Pain--Impact of the S3 Guidelines for the Field of Orthopaedic Surgery and Trauma Surgery]. (2016) (2)
Gespräche über das Lebensende (2002) (2)
Was sind die „Kernsymptome“ des Fibromyalgiesyndroms“? – Ein faktorenanalytischer Ansatz (2008) (2)
Cannabis, Cannabinoide und das Endocannabinoidsystem (2019) (2)
Kritische Auseinandersetzung mit neuen Daten zur Prävalenz von Opioidgebrauchsstörungen bei Patienten mit chronischen Schmerzen in Deutschland (2021) (2)
Multimodale Therapie des Fibromyalgiesyndroms (2008) (2)
Diagnostische Kriterien von und therapeutische Strategien bei Schmerzen des Magen-Darm-Trakts und der Beckenorgane (2002) (1)
Structure of S-3 medical guidelines—Implications for CAM researchers (2009) (1)
Entspannung und Imagination (Selbsthypnose) (2010) (1)
Konzepte einer psychosomatischen Gastroenterologie (1999) (1)
Hypnose bei akuten und chronischen Schmerzen — Möglichkeiten und Grenzen (2007) (1)
Ist eine evidenzbasierte Therapie von stationären Typ-2-Diabetikern mit den zur Leitlinienerstellung verwendeten Studien möglich? (2005) (1)
Gemeinsam klug entscheiden in der Schmerzmedizin (2017) (1)
[Chronic chest pain]. (2014) (1)
Viktor von Weizsäckers Medizinische Anthropologie und der systemische Ansatz in der Medizin (1987) (1)
Non-pharmacological interventions for fibromyalgia (fibromyalgia syndrome) in adults: an overview of Cochrane Reviews (2022) (1)
[About the article from Madisch A et al. Impact of reflux disease on general and disease-related quality of life--evidence from a recent comparative methodological study in Germany. Z.Gastroenterol 2003;41:1137-1143]. (2004) (1)
Fibromyalgia: New Clinical Concepts (2015) (1)
[And the opioid pendulum still swings between uncritical indication and overcritical restriction]. (2020) (1)
Viszeraler Schmerz (2015) (1)
Schmerzbewältigungstraining für Patienten mit chronisch rheumatischen Schmerzen in der medizinischen Regelversorgung (1997) (1)
[Visceral pain--a neglected phenomenon in pain therapy and research?]. (2002) (1)
Diagnostic and therapeutic care pathway for fibromyalgia. (2021) (1)
Additions required. (2013) (1)
Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (D (2022) (1)
[Increased demand for psychosomatic consultation service (C-service) in a department of cardiology/pneumology due to psychometric screening]. (2001) (1)
Comment on: Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. Reply. (2020) (1)
[Errors and Solutions During Medical Therapy for Chronic Pain]. (2018) (1)
[Erratum to: Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]. (2015) (1)
Comparative ef fi cacy of pharmacological and non-pharmacological interventions in fi bromyalgia syndrome : network meta-analysis (2012) (1)
[Erratum to: Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain]. (2015) (1)
[Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling]. (2019) (1)
[Prospective epidemiological study of epigastric complaints (PRESTO)]. (2000) (1)
Fibromyalgia criteria and anomalous results: comment on the article by Ghavidel‐Parsa et al (2022) (1)
[Fibromyalgia syndrome - updated s3 guidelines]. (2013) (1)
[Pain management in patients with chronic rheumatic pain--a model for primary medical care]. (1997) (1)
Erratum zu: Definition, Klassifikation, klinische Diagnose und Prognose des Fibromyalgiesyndroms (2017) (1)
Ernährungstherapie bei Essstörungen (2003) (1)
Kapitel 82 – Chronisch entzündliche Darmerkrankungen (2017) (1)
Diagnostik und Therapie des Fibromyalgiesyndroms Diagnosis and Therapy of Fibromyalgia Syndrome (2011) (1)
Psychosomatik in der Gastroenterologie – Stellungnahme der Arbeitsgemeinschaft Psychosomatik in der Gastroenterologie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2018) (1)
Das Fibromyalgiesyndrom – aktualisierte S3-Leitlinie (2013) (1)
Pharmakotherapie der Essstörungen (2008) (1)
[Fibromyalgia syndrome guideline: Interim assessment]. (2012) (1)
Unklare chronische Schmerzen Ist es ein Fibromyalgie-Syndrom? (2009) (1)
Medikamentöse Therapie des Fibromyalgiesyndroms (2008) (1)
Reply (2011) (1)
[Diagnostic evaluation of chronic pelvic pain]. (2010) (1)
Nicht-spezifische, funktionelle und somatoforme Körperbeschwerden – Relevanz für die Schmerzmedizin (2014) (1)
[Chronic pain disorder with somatic and psychological factors : A diagnosis initiated by professional politics awaits its scientific validation]. (2018) (1)
Umgang mit Patientinnen mit chronischem Unterbauchschmerz aus schmerzmedizinischer und psychosomatischer Perspektive (2015) (1)
[Fibromyalgia syndrome. Rheumatic disease or a mental disorder?]. (2007) (1)
EXPRESSION OF BETA-ADRENERGIC RECEPTORS IN HYPOTHALAMO-PITUITARY-ADRENALAXIS DURING DEVELOPMENT OF SPONTANEOUS HYPERTENSION IN RATS: OP 164 (2004) (1)
Viszerale Schmerzen (2014) (1)
Systemische Therapie bei Angststörungen (2000) (1)
Cannabis (2019) (1)
Opioids in chronic neuropathic pain (2015) (1)
Evidenz der Wirksamkeit und Sicherheit von Cannabispräparaten bei chronischen Schmerzen (2019) (1)
Nikotinabhängigkeit und Motivation zur Raucherentwöhnung bei Patienten einer kardiologisch-pneumologischen Akutklinik (2002) (1)
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain) (2022) (1)
4-ANXIETY AND DEPRESSION IN ULCERATIVE COLITIS AND ILEAL POUCH ANAL ANASTOMOSIS (2004) (1)
[Post COVID - Just a matter of definition?] (2022) (1)
Symptom Increase in Fibromyalgia Is Not Consistent with the Central Sensitization or Central Hyperresponsiveness Hypothesis (2014) (1)
In Reply. (2019) (0)
Reply to: Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia (2023) (0)
[Healthcare services research on pain in Germany. A survey]. (2015) (0)
Patient Doctor Relationship Questionnaire-9--German Version (2016) (0)
[Diagnosis fibromyalgia: How to diagnose and treat]. (2016) (0)
In reply. (2015) (0)
Reply to Chaturvedi. (2020) (0)
6-DISEASE RELATED WORRIES AND COMORBIDITIES DETERMINE QUALITY OF LIFE IN CHRONIC HEPATITIS (2004) (0)
Concerns about the taxonomy, definition and coding of fibromyalgia syndrome in ICD-11: the potential for negative consequences for patient care and research. (2022) (0)
[Benefits and harms of cannabis-based medicines from the viewpoint of patients with chronic pain and their physicians : A cohort study in three pain centers of the German federal state Saarland]. (2023) (0)
[Fibromyalgia syndrome: what antidepressants cannot do]. (2009) (0)
[Updated S1 guideline on long/post-COVID: relevant aspects for pain medicine]. (2023) (0)
Anticonvulsants for fibromyalgia (Review) (2013) (0)
[Erratum to: Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. (2017) (0)
Update Fibromyalgiesyndrom (2020) (0)
[Method report of the second update of the guidelines on long-term opioid therapy for chronic noncancer pain]. (2020) (0)
Functional Somatic Disorders, Their Subtypes, and Their Association With Self-Rated Health in the German General Population (2023) (0)
This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. The Role of Antidepressants in the Management of Fibromyalgia Syndrome A Systematic Review and Meta-Analysis (2012) (0)
[Fibromyalgia syndrome: diagnostic criteria and treatment]. (2009) (0)
In Reply. (2018) (0)
Reply to ‘Imbalance of threat and soothing systems in fibromyalgia: rephrasing an established mechanistic model?’ (2023) (0)
Mild Water-Filtered Infrared-A Whole-Body Hyperthermia Reduces Pain in Patients with Fibromyalgia Syndrome—A Randomized Sham-Controlled Trial (2023) (0)
Prevalence of self-reported jaw pain in Germany: two cross-sectional surveys of the general German population (2015) (0)
[Colitis ulcerosa and opioid addiction]. (2002) (0)
Prescriptions of cannabinoid drugs, 2019–2022—a comparison of data from the German Federal Institute for Drugs and Medical Devices and the BARMER health insurance fund (2023) (0)
Leitlinie Fibromyalgiesyndrom (2012) (0)
Population Survey Evidence from a Representative German − − ' ' Fibromyalgia Syndrome ' ' A Cluster Within the Continuum of Biopsychosocial Distress Can Be Labeled (2009) (0)
The Polysymptomatic Distress Scale and the Effect of Age On Polysymptomatic Distress and Fibriomyalgia: A Survey in a Representative Population Sample (2012) (0)
Reply to Goebel and Molloy. (2021) (0)
Substantially Broader Scope of Use Reply (2017) (0)
RE: Physician decisions about medical cannabis should be based on evidence, not hype or public pressure (2020) (0)
How does percutaneous ethanol injection compare with acetic acid injection or surgery in people with early hepatocellular carcinoma (2016) (0)
[Functional gastrointestinal disorders]. (2022) (0)
Non-specific, functional and somatoform bodily complaints. S3 guidelines and patient version (2014) (0)
51 EUROPEAN GUIDELINES ON FIBROMYALGIA SYNDROME – PATHOGENESIS AND MANAGEMENT (2011) (0)
[Erratum to: Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety]. (2019) (0)
[Psychosomatics and epistemology. Principles and changes in the concept of psychosomatics]. (1985) (0)
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review (2022) (0)
Authors reply to the comment of Bäckryd et al. (2022) (0)
[Hypnosis in gastroenterology]. (2003) (0)
Additional file 4 of All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study (2020) (0)
Cannabis-based medicines and medical cannabis for adults with cancer pain (2022) (0)
Medical cannabis and cannabis-based medicines: an appeal to doctors, journalists, health insurance companies and politicians for responsible treatment (2019) (0)
11 Topical Seminar Summary: FIBROMYALGIA SYNDROME (2009) (0)
150 A COMPARISON OF THE US‐AMERICAN AND GERMAN GUIDELINE WITH EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF FIBROMYALGIA (2009) (0)
Corrigendum to “Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy—Magnitude and patient-related predictors” [PAIN® 152 (8) (2011) 1709–1717] (2012) (0)
Mo1335 Mucosal Healing, Depression and Stress Did Not Predict Relapse of Ulcerative Colitis Patients in Clinical Remission Not on Immunosuppressive Drugs: A Prospective 12-Months Follow-up Study (2013) (0)
[Choosing wisely together in pain medicine]. (2017) (0)
[Pain therapy-neglected by gynecology? Endometriosis-neglected by pain medicine?] (2021) (0)
Diagnosisanddiagnostictests forfibromyalgia(syndrome) (2012) (0)
articleEfficacy of different types of aerobic exercise in fibromyalgia syndrome : a systematic review and meta-analysis of randomised controlled trials (2015) (0)
Fibromyalgia revisited: do latent class analyses of symptom profiles in the general population confirm 2016 fibromyalgia diagnostic criteria? (2021) (0)
Associations of different types of child maltreatment and diabetes in adulthood - the mediating effect of personality functioning: Findings from a population-based representative German sample. (2022) (0)
Guidelines for Classification and Diagnosis of Fibromyalgia Spanning Three Continents (2014) (0)
THU0358 The german fibromyalgia consumer reports – a cross-sectional survey (2013) (0)
Reply to Dr. Suvak et al.'s letter (2011) (0)
I41. Managing Fibromyalgia: What Works and What Doesn't (2014) (0)
[The effectiveness of adjunctive hypnosis with surgical patients. A meta-analysis]. (2003) (0)
In patients undergoing pancreatic surgery, what are the benefits and harms of post‐operative administration of somatostatin analogues? (2016) (0)
[Sports and the digestive tract]. (1991) (0)
[Psychosomatics in gastroenterology - statement of the Work Group for Psychosomatics in Gastroenterology of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]. (2018) (0)
First Results From the Celiac Disease Health-Related Quality of Life Questionnaire in Turkey: Potential Impact of Nutrition Status on Health-Related Quality of Life in Adult Patients With Celiac Disease: 1207 (2017) (0)
[Critical discussion of new data regarding prevalence of opioid use disorder in patients with chronic pain in Germany]. (2021) (0)
[Hypnosis in medical practice. A healing method or quackery? (interview by Dipl.-Biol. Waldtraud Paukstadt)]. (2001) (0)
310-FIBROMYALGIA- PSYCHOSOCIAL RISK FACTORS AND PREDICTORS OF HEALTH CARE UTILIZATION IN A NON-THERAPEUT (2004) (0)
A new national German guideline on non-specific, functional and somatoform bodily complaints (2013) (0)
[Functional somatic pain syndromes]. (2004) (0)
[Chronic abdominal pain--internistic-psychosomatic aspects]. (2004) (0)
Untying chronic pain (2014) (0)
[Diagnosis and therapy of functional dyspepsia]. (1994) (0)
Acute Abdomen in Chronic Anorexia Nervosa with Episodes of Bulimia. (2019) (0)
[Erratum to: Long-term therapy with opioids for chronic non-tumor-related pain. Systematic Review and Meta-analysis of the efficacy, tolerability and security in open connection studies over at least 26 weeks]. (2015) (0)
OP0192 Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia (2013) (0)
[Comment on consensus report: Irritable bowel syndrome--definition, verifying the diagnosis, pathophysiology and therapeutic options]. (2000) (0)
Differential expression of β1- and β2-adrenergic receptors in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats (2003) (0)
In Reply. (2017) (0)
[Erratum to: Opioids for chronic non-tumor-related pain--are not opioid analgesics superior? Systematic Review and Meta-analysis of Efficacy, tolerability and safety in randomized direct comparison of opioids and non-opioid analgesia for at least 4 weeks]. (2015) (0)
[Comorbidity of internal inpatients in the german diagnosis related groups-system]. (2005) (0)
[Psychosomatic aspects of Crohn disease]. (1985) (0)
[Twelve years of the S3 guideline Fibromyalgia Syndrome-a never-ending war?] (2017) (0)
Face validity of the ICD‐10 criteria of substance abuse and dependence for patients prescribed cannabis‐based medicines for chronic pain—A survey of pain medicine physicians in Canada, Germany and Israel (2023) (0)
Antipsychotics for fibromyalgia (2015) (0)
Erratum zu: Cannabispräparate bei chronischen Schmerzen: Indikationen, Präparateauswahl, Wirksamkeit und Sicherheit (2019) (0)
Postmoderne Literatur und systemische Therapie 2. Ordnung (1990) (0)
Ambulante Therapiekombinationen (1999) (0)
Was Ärzte erwarten, beeinflusst das Therapie-Ergebnis (2013) (0)
Fehler und Lösungen bei der medikamentösen Therapie chronischer Schmerzen (2018) (0)
Die Lebensqualität bei chronischen Erkrankungen–funktionelle Dyspepsie vs. chronische Lebererkrankungen (2004) (0)
Psychotherapeutische Verfahren beim Fibromyalgiesyndrom (2014) (0)
Das irritable Pouch-Syndrom ist mit Depressivität assoziiert und kann durch die Quantifizierung mukosaler Zytokintranskripte von einer Pouchitis differenziert werden (2007) (0)
Eng verknüpft: Fibromyalgie und posttraumatische Belastungsstörungen (2013) (0)
Die Rolle von Antidepressiva in der Therapie des Fibromyalgiesyndroms (2010) (0)
Organ der Deutschen Schmerzgesellschaft e.V., der Österreichischen Schmerzgesellschaft, der Deutschen Interdisziplinären Vereinigung für Schmerztherapie und der Schweizerischen Gesellschaft zum Studium des Schmerzes (2013) (0)
Psychotherapie des Fibromyalgie-Syndroms – eine Meta-Analyse kontrollierter Studien (2009) (0)
Antwort der Autoren (2003) (0)
Möglichkeiten und Grenzen psychosomatischer Forschung bei stationär behandelten Typ 2 Diabetikern (2005) (0)
Blüten, Öle oder überhaupt nicht? (2019) (0)
Placebo bei Fibromyalgie – aber wie? (2012) (0)
Aktualisierte S1-Leitlinie Long/Post-COVID: Relevante Aspekte für die Schmerzmedizin (2023) (0)
Chronische Schmerzen in Deutschland: Prävalenz und sozioökonomische Relevanz (2013) (0)
Wirksamkeit psychotherapeutischer Interventionen bei der Behandlung des Fibromyalgie-Syndroms – Eine Meta-Analyse kontrollierter und nicht-kontrollierter Studien (2009) (0)
Ansätze zu einer integrativen Theorie chronisch entzündlicher Darmerkrankungen (1987) (0)
Psychosomatische Aspekte chronischer Lebererkrankungen (2007) (0)
Stressinduzierte Hyperalgesie (2017) (0)
Funktionelle gastrointestinale Störungen (2012) (0)
Und immer noch schwingt das Opioidpendel zwischen unkritischer Indikation und überkritischer Restriktion (2020) (0)
Cannabis-basierte Medizin - wirksame Therapie oder Kiffen auf Rezept? (2020) (0)
Fibromyalgiesyndrom: Definition und Differen zialdiagnosen (2013) (0)
Was muss der Hausarzt abklären? (2016) (0)
Welche Cannabis-basierten Arzneimittel gibt es? (2020) (0)
Erratum zu: Opioide bei chronischem Kreuzschmerz (2015) (0)
Diagnostik und Therapie des Reizdarmsyndroms (2011) (0)
Schmerz und Bewusstsein (2007) (0)
32. Psychosomatik (2018) (0)
Fibromyalgie: wie sichern, wie behandeln? (2016) (0)
S3-Leitlinie zum Fibromyalgiesyndrom – Differenzialdiagnose und Therapie (2013) (0)
Schmerztherapie – ein Stiefkind der Frauenheilkunde? Endometriose – ein Stiefkind der Schmerzmedizin? (2021) (0)
Prävalenz und soziökonomische Relevanz (2012) (0)
Post-COVID: Alles eine Frage der Definition? (2022) (0)
Raucherentwöhnung: Eine ärztliche Aufgabe (2002) (0)
Der Angiotensin-AT 1 -Rezeptorantagonist CV 11974 reguliert den zerebralen Fluß und die Angiotensin-AT 1 -Rezeptorexpression im Gehirn (1999) (0)
Nutzung von Cannabis bei Patienten chronisch entzündlichen Darmerkrankungen in Deutschland (2020) (0)
Ad-hoc-Kommission der Deutschen Schmerzgesellschaft „ Cannabis in der Medizin “ · Matthias Karst (2019) (0)
Entspannung und Imagination (Selbsthypnose) Individuelle Ressourcen für Patienten mit einer Krebserkrankung (2010) (0)
Das Fibromyalgiesyndrom: Was hilft wirklich? (2013) (0)
Cannabidiol - Hoffnung oder Rummel? (2020) (0)
Prävalenz von chronischen, invalidisierenden Schmerzen (2016) (0)
Angiotensin-Converting Enzyme Inhibitors and AT 1-Receptor Antagonist Restore Nitric Oxide Synthase ( NOS ) Activity and Neuronal NOS Expression in the Adrenal Glands of Spontaneously Hypertensive Rats (2001) (0)
Anorexia nervosa und Bulimia nervosa (1999) (0)
Chronischer Brustschmerz (2014) (0)
Effektivität von Hypnose als Ergänzung anästhesiologischer Verfahren in der operativen Medizin (2003) (0)
Wirksamkeit von Antidepressiva beim Fibromyalgiesyndrom–Eine Metaanalyse (2008) (0)
Die Schwere gastroenterologischer und hepatologischer Erkrankungen: ein Vergleich von Patienten mit Leberzirrhose und Funktioneller Dyspepsie (2004) (0)
Schmerzmedizin bei Fibromyalgiesyndrom (2019) (0)
Der Childhood Trauma Screener (CTS) – Entwicklung und Validierung von Schwellenwerten zur Klassifikation (2013) (0)
Mucosale proinflammatorische Zytokine und Depressivität bei Patienten mit ileoanalem Pouch bei Colitis ulcerosa (2007) (0)
Nutzen und Schaden von Cannabisarzneimitteln aus Sicht von Patienten mit chronischen Schmerzen und ihren Ärzten (2023) (0)
Wirksamkeit multimodaler Therapie beim Fibromyalgiesyndrom–Eine Metaanalyse (2008) (0)
Aktualisierte S3-Leitlinie Colitis ulcerosa (2019) (0)
Fibromyalgie: Bewertung der Somatic Symptom Disorder (2015) (0)
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline (2020) (0)
H9 – Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren Körperregionen und des so genannten Fibromyalgiesyndroms bei Kindern und Jugendlichen1 (S3) (2015) (0)
Bauchschmerz aus internistisch-psychosomatischer Sicht: Gestresster Magen: Gereizter Darm? (2004) (0)
Opioidsucht bei Colitis ulcerosa (2002) (0)
Nutzung von komplementären und naturheilkundlichen Verfahren bei chronisch entzündlichen Darmerkrankungen in Deutschland (2019) (0)
mRNA and protein expression of nitric oxide synthase isoforms in the hypothalamo-pituitary-adrenal axis of streptozotocin-induced diabetic rats (2003) (0)
Psychosomatische Askpekte der Zöliakie (2007) (0)
Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten (2020) (0)
Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen: Bedeutung der S3-Leitlinie LONTS für das Fachgebiet Orthopädie und Unfallchirurgie (2016) (0)
Grundlagen der klinischen Pharmakologie (2015) (0)
Pharmakotherapie in der Psychoonkologie (2008) (0)
Psychologische Aspekte in der Pathogenese und Therapie des Reizdarmsyndroms (2022) (0)
OP0068 Mediation of childhood/adolescence maltreatment and adult fibromyalgia syndrome by depression – a case control study (2013) (0)
SP0061 Fibromyalgia – What Really Works? from Ancient to Recent Managements (2014) (0)
[Visceral pain. Still a poor relation of pain medicine?]. (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Winfried Häuser?

Winfried Häuser is affiliated with the following schools:

Winfried Häuser's Academic­Influence.com Rankings

Why Is Winfried Häuser Influential?

Winfried Häuser's Published Works

Published Works

What Schools Are Affiliated With Winfried Häuser?

Winfried Häuser's AcademicInfluence.com Rankings